# Foamix Pharmaceuticals Ltd.

Foamix Pharmaceuticals Ltd. is a company headquartered in Rehovot, Israel.

## Company overview

- **Legal name:** Foamix Pharmaceuticals Ltd.
- **Former names in filing history:** Foamix Ltd. (2014-05-20 to 2014-08-13)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Rehovot, Israel
- **Incorporated in:** L3
- **Fiscal year end:** December 31
- **SEC CIK:** 0001606645

## About

Foamix Pharmaceuticals Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001606645, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2020-03-12, it reported annual revenue of USD 443,000; net income of USD -95,178,000; total assets of USD 81,159,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $443,000 (USD 443,000)
- **Net income:** -$95.2M (USD -95,178,000)
- **Total assets:** $81.2M (USD 81,159,000)
- **Cash and equivalents:** $43.8M (USD 43,759,000)
- **Operating cash flow:** -$73.4M (USD -73,394,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $3.6M (USD 3,595,000)
- **Net income:** -$74.2M (USD -74,163,000)
- **Total assets:** $103.7M (USD 103,731,000)
- **Cash and equivalents:** $27.9M (USD 27,868,000)
- **Operating cash flow:** -$68.7M (USD -68,664,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $3.7M (USD 3,669,000)
- **Net income:** -$65.7M (USD -65,715,000)
- **Total assets:** $80.3M (USD 80,254,000)
- **Cash and equivalents:** $16.0M (USD 15,956,000)
- **Operating cash flow:** -$53.2M (USD -53,177,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $5.5M (USD 5,527,000)
- **Net income:** -$29.3M (USD -29,336,000)
- **Total assets:** $135.6M (USD 135,635,000)
- **Cash and equivalents:** $31.2M (USD 31,190,000)

## Recent SEC filings

- Form 10-K — filed 2020-03-12 — period 2019-12-31 — 10-K
- Form 8-K — filed 2020-03-12 — period 2020-03-12 — 8-K
- Form 8-K — filed 2020-03-10 — period 2020-03-09 — FROM 8-K
- Form 8-K — filed 2020-02-06 — period 2020-02-06 — FORM 8-K
- Form 8-K — filed 2020-01-14 — period 2020-01-14 — FORM 8-K
- Form 8-K — filed 2020-01-09 — period 2020-01-09 — FORM 8-K
- Form 8-K — filed 2019-12-18 — period 2019-12-17 — FORM 8-K
- Form 8-K — filed 2019-12-16 — period 2019-12-16 — FORM 8-K
- Form 8-K — filed 2019-12-04 — period 2019-12-04 — FORM 8-K
- Form 10-Q — filed 2019-11-12 — period 2019-09-30 — 10-Q
- Form 8-K — filed 2019-11-12 — period 2019-11-12 — 8-K
- Form 8-K — filed 2019-11-12 — period 2019-11-12 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/foamix-pharmaceuticals-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology